This paper is in the following e-collection/theme issue:

Diabetes Self-Management (484) Registered Report (561)

Published on in Vol 7, No 2 (2022): Apr-Jun

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/31832, first published .
Evaluation of Self-care Activities and Quality of Life in Patients With Type 2 Diabetes Treated With Metformin Using the 2D Matrix Code of Outer Drug Packages as Patient Identifier: the DePRO Proof-of-Concept Observational Study

Evaluation of Self-care Activities and Quality of Life in Patients With Type 2 Diabetes Treated With Metformin Using the 2D Matrix Code of Outer Drug Packages as Patient Identifier: the DePRO Proof-of-Concept Observational Study

Evaluation of Self-care Activities and Quality of Life in Patients With Type 2 Diabetes Treated With Metformin Using the 2D Matrix Code of Outer Drug Packages as Patient Identifier: the DePRO Proof-of-Concept Observational Study

Authors of this article:

Christian Mueller1 Author Orcid Image ;   Isabel Schauerte2 Author Orcid Image ;   Stephan Martin3 Author Orcid Image ;   Valeska Irrgang1 Author Orcid Image
Article Authors Cited by (1) Tweetations (2) Metrics

Christian Mueller   1 , PhD ;   Isabel Schauerte   2 , PhD ;   Stephan Martin   3 , MD ;   Valeska Irrgang   1 , MD

1 Bayer Vital GmbH, Leverkusen, Germany

2 Institut Dr. Schauerte, Munich, Germany

3 Westdeutsches Diabetes- und Gesundheitszentrum, Düsseldorf, Germany

Corresponding Author: